4-(2-氟-4-硝基苯基)吗啉 | 2689-39-6

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 中文名称: 4-(2-氟-4-硝基苯基)吗啉
• 中文别名: 3-氟-4-吗啉基硝基苯；2-氟-4-硝基苯基吗啉
• 英文名称: 3-fluoro-4-(4-morpholinyl)nitrobenzene
• 英文别名: 4-(2-fluoro-4-nitrophenyl)morpholine；3-fluoro-4-morpholinylnitrobenzene；3-fluoro-4-morpholinonitrobenzene；3-fluoro-4-(morpholin-4-yl)-nitrobenzene
• CAS: 2689-39-6
• 化学式: C₁₀H₁₁FN₂O₃
• mdl: MFCD03138381
• 分子量: 226.207
• InChiKey: ZEQCFSSBZPZEFJ-UHFFFAOYSA-N

物化性质

• 熔点：
  121-126℃
• 沸点：
  380.9±42.0 °C(Predicted)
• 密度：
  1.340±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  58.3
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934999090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
4-(2-Fluoro-4-nitrophenyl)morpholine
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
4-(2-Fluoro-4-nitrophenyl)morpholine
Ingredient name:
CAS number: 2689-39-6

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H11FN2O3
Molecular weight: 226.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(2-氟-4-硝基苯基)吗啉 在 1H-1,2,4-三唑 、 dimethyl sulfide borane 、 palladium on activated charcoal 、 氢气 、 三乙胺 、 N,N-二异丙基乙胺 、 双(咪唑-1-基)亚砜 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， -30.0~20.0 ℃ 、101.33 kPa 条件下， 反应 37.25h， 生成 利奈唑胺
  参考文献：
  名称：

  通过衍生自手性结构单元异丝氨酸的恶唑烷-2,4-二酮中间体方便地合成抗生素利奈唑胺

  摘要：

  我们描述了对映异构纯形式的利奈唑胺的 5-(氨基甲基) 恶唑烷-3-one 核心的新合成。衍生自异丝氨酸和 3-氟-4-吗啉代苯胺的 α-羟基酰胺方便的环化得到相应的（氨甲基）恶唑烷-2,4-二酮，然后在 C(4)-位进行温和的选择性还原，以几乎定量的总产率得到利奈唑胺。

  DOI：

  10.1002/ejoc.201402888
• 作为产物：
  描述：

  1,2-二氟苯 在 硫酸 、 硝酸 作用下， 以 二甲基亚砜 为溶剂， 反应 8.0h， 生成 4-(2-氟-4-硝基苯基)吗啉
  参考文献：
  名称：

  含氟3-氨基-1,2,4-苯并三嗪合成中硝基参与氢亲核取代与环缩合的串联

  摘要：

  在 ButOK 存在下，3-氟-1-硝基苯与盐酸胍在 THF 中的反应得到异构的含 5-和 7-氟的 3-氨基-1,2,4-苯并三嗪。

  DOI：

  10.1007/s11172-006-0406-9

文献信息

• Application of Silicon-Initiated Water Splitting for the Reduction of Organic Substrates
  作者：Ashot Gevorgyan、Satenik Mkrtchyan、Tatevik Grigoryan、Viktor O. Iaroshenko

  DOI：10.1002/cplu.201800131

  日期：2018.5

  several important classes of organic compounds is described. It is found that the reductive water splitting can be promoted by several metalloids among which silicon shows the best efficiency. The developed methodologies were applied for the reduction of nitro compounds, N-oxides, sulfoxides, alkenes, alkynes, hydrodehalogenation as well as for the gram-scale synthesis of several substrates of industrial

  描述了使用水作为氢的供体，其适合于还原几种重要类别的有机化合物。发现还原水分解可以通过几种准金属来促进，其中硅显示出最佳的效率。所开发的方法学被用于还原硝基化合物，N-氧化物，亚砜，烯烃，炔烃，加氢脱卤作用以及几种工业上具有重要意义的底物的克级合成。
• Biorenewable carbon-supported Ru catalyst for <i>N</i>-alkylation of amines with alcohols and selective hydrogenation of nitroarenes
  作者：Vishakha Goyal、Naina Sarki、Mukesh Kumar Poddar、Anand Narani、Deependra Tripathi、Anjan Ray、Kishore Natte

  DOI：10.1039/d1nj01654g

  日期：——

  prepared via simple impregnation followed by the pyrolysis process. The prepared Ru/PNC-700 catalyst demonstrated remarkable catalytic activity in terms of conversion and selectivity towards N-alkylation of anilines with benzyl alcohol and chemoselective hydrogenation of aromatic nitro compounds. In addition, local anesthetic pharmaceutical agents (e.g., butamben and benzocaine), including key drug intermediates

  在此，我们开发了一种可再生的碳负载 Ru 催化剂（Ru/PNC-700），该催化剂通过简单的浸渍和热解过程轻松制备。制备的 Ru/PNC-700 催化剂在苯胺与苯甲醇的N-烷基化和芳香硝基化合物的化学选择性加氢的转化率和选择性方面表现出显着的催化活性。此外，局部麻醉药剂（例如、丁苯苯和苯佐卡因），包括关键的药物中间体，在温和的条件下和作为绿色溶剂的水的存在下以优异的产率合成。此外，制备的 Ru/PNC-700 催化剂可以很容易地回收和重复使用多达 5 次，而没有任何明显的活性和选择性损失。
• Simple RuCl ₃ ‐catalyzed <i>N</i> ‐Methylation of Amines and Transfer Hydrogenation of Nitroarenes using Methanol
  作者：Naina Sarki、Vishakha Goyal、Nitin Kumar Tyagi、Puttaswamy、Anand Narani、Anjan Ray、Kishore Natte

  DOI：10.1002/cctc.202001937

  日期：2021.4.9

  readily available feedstock chemicals, highlighting synthetic value of this advanced N‐methylation reaction. Using this platform, we also attempted tandem reactions with selected nitroarenes to convert them into corresponding N‐methylated amines using MeOH under H2‐free conditions including transfer hydrogenation of nitroarenes‐to‐anilines and prepared drug molecules (e. g., benzocaine and butamben) as well

  甲醇是潜在的氢源和C 1合成子，在化学合成和能源技术中都有有趣的应用。在有机合成中有效利用这种简单的醇具有至关重要的意义，并引起了科学兴趣。本文中，我们报道了一种清洁且具有成本竞争力的方法，该方法使用甲醇作为C 1合成子和H 2源，通过使用相对便宜的RuCl 3 .xH 2 O作为无配体催化剂，对胺进行选择性N-甲基化。这种易于获得的催化剂可耐受各种包含缺电子基团和供电子基团的胺，并使它们转化为相应的N甲基化产品，产率中等至优异。此外，很少有市售的药剂（例如文拉法辛和丙咪嗪）是通过后期功能化从容易获得的原料化学品中成功合成的，从而突出了这种先进的N-甲基化反应的合成价值。在该平台上，我们还尝试与选定的硝基芳烃进行串联反应，以在H 2下使用MeOH将它们转化为相应的N甲基化胺。无条件的条件包括硝基芳烃到苯胺的转移氢化以及制备的药物分子（例如苯佐卡因和丁苯本）以及关键的医药中间体。我们进一步使
• Anti-Viral Compounds
  申请人：DeGoey David A.

  公开号：US20100317568A1

  公开（公告）日：2010-12-16

  Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

  描述了一种有效抑制丙型肝炎病毒（“HCV”）复制的化合物。本发明还涉及制备这种化合物的方法、包含这种化合物的组合物，以及使用这种化合物治疗HCV感染的方法。
• Therapeutic heterocyclic compounds
  申请人：——

  公开号：US20030013708A1

  公开（公告）日：2003-01-16

  Provided herein is a compound having the formula (I): 1 Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT 1B and 5HT 1D antagonists.

  本文提供的化合物具有以下式（I）： 其中所述化合物可用于治疗精神障碍，包括但不限于抑郁症、广泛性焦虑、进食障碍、痴呆症、恐慌障碍和睡眠障碍。这些化合物还可能用于治疗胃肠道障碍、心血管调节、运动障碍、内分泌障碍、血管痉挛和性功能障碍。这些化合物是5HT 1B和5HT 1D拮抗剂。